Ronald M. McGuff, President, McGuff Pharmaceutical, Inc. (McGuff) announced today that the company has completed design and has begun construction of a new 86,000 sq. ft. state-of-the-art, aseptic fill, pharmaceutical manufacturing facility in Santa Ana, California. Mr. McGuff has indicated “this facility represents our long term commitment to meet our customer’s needs for a diverse number of high quality injectable drug products at an affordable price.” This new facility is designed to meet the customer’s demand for:
Mr. McGuff states “The new McGuff facility will be capable of manufacturing high-quality sterile drugs in large and small quantities and is designed to meet US, EU and Japanese regulatory requirements. The facility will be capable of producing sterile potent, non-potent, controlled substance and hazardous drugs in liquid and lyophilized vials, cartridges, and syringes. All produced within an isolator environment.”
The McGuff Family of Companies has a 45 year history of excellence in the pharmaceutical and medical product markets. “This facility is designed to provide flexible outcomes in pharmaceutical aseptic production that will provide our internal and external customers with rapid turnaround times for small or large aseptic processing.” Said Mr. McGuff.
Today, McGuff Pharmaceuticals, Inc., a division of McGuff Company, remains a family and veteran owned company. McGuff Pharmaceuticals, Inc. is a Food and Drug Administration inspected sterile fill manufacturer, that maintains a tradition of quality and core competency in current Good Manufacturing Practices .
Mr. McGuff added in closing, “McGuff’s greatest asset is and always will be our employees. Without their dedication and hard work to provide customers with personalized services, high-quality products, and great customer care none of this would be possible. McGuff and its employees continue to ensure the stable supply of high-quality drugs to patients around the world.”